Journal
DIABETES OBESITY & METABOLISM
Volume 12, Issue -, Pages 76-82Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1463-1326.2010.01279.x
Keywords
diabetes; endoplasmic reticulum stress; free fatty acids; islets; lipotoxicity; oleate; palmitate; pancreatic beta-cells; unfolded protein response
Categories
Funding
- European Union [CEED3]
- European Community
- European Foundation for the Study of Diabetes
- FNRS (Fonds National de la Recherche Scientifique)
- FRSM (Fonds de la Recherche Scientifique Medicale), Belgium
- CAPES (Brazilian Coordination for the Improvement of Higher Education Personnel)
Ask authors/readers for more resources
Pancreatic beta-cell dysfunction is central to the pathogenesis of type 2 diabetes, and the loss of functional beta-cell mass in type 2 diabetes is at least in part secondary to increased beta-cell apoptosis. Accumulating evidence suggests that endoplasmic reticulum (ER) stress is present in beta-cells in type 2 diabetes. Free fatty acids (FFAs) cause ER stress and are putative mediators of beta-cell dysfunction and death. In this review, we discuss the molecular mechanisms underlying ER stress induced by saturated and unsaturated FFAs. Oleate and palmitate trigger ER stress through ER Ca2+ depletion and build-up of unfolded proteins in the secretory pathway. Saturated and unsaturated FFAs elicit a differential signal transduction in the three branches of the ER stress response, resulting in different survival/apoptosis outcomes. The protection of beta-cells against FFAs through the interference with ER stress signalling has opened novel therapeutic perspectives for type 2 diabetes. Chemical chaperones, salubrinal and glucagon-like peptide-1 (GLP-1) analogues have been used to protect beta-cells from lipotoxic ER stress. Importantly, the pro- and antiapoptotic effects of these compounds are cell and context dependent.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available